| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/26/2002 | EP1007072A4 Glial cell line-derived neurotrophic factor receptors |
| 06/26/2002 | EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists |
| 06/26/2002 | EP0877614B1 Method for inducing death of neoplastic cells using piperazine oxirane derivatives |
| 06/26/2002 | EP0830137A4 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 06/26/2002 | EP0773785B1 Treatment of cancer using hsv mutant |
| 06/26/2002 | EP0580790B1 Method for potentiating primary drugs in treating multidrug resistant cells |
| 06/26/2002 | CN1355881A Growth differentiation factor inhibitors and uses therefor |
| 06/26/2002 | CN1355850A Hyaluronidase from hirudinaria manillensis, isolation, purification and recombinant method of production |
| 06/26/2002 | CN1355844A Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355810A Prodrugs of thrombin inhibitors |
| 06/26/2002 | CN1355809A Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 06/26/2002 | CN1355789A Indigoid bisindole derivatives |
| 06/26/2002 | CN1355782A Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
| 06/26/2002 | CN1355711A Method for inhibiting brain tumor growth |
| 06/26/2002 | CN1355709A Tumor vaccines |
| 06/26/2002 | CN1355704A Method for preparing membrane visicles |
| 06/26/2002 | CN1355702A Use of arylalkanoylpyridazines |
| 06/26/2002 | CN1355701A Urea substituted imidazoquinolines |
| 06/26/2002 | CN1355695A Compounds useful in reducing level of insulin like growth factor-I (IGF-I) in blood |
| 06/26/2002 | CN1355691A Antibody and polyalkylene glycol-bonded liposome |
| 06/26/2002 | CN1355672A Method of increasing content of flavonoids and phenolic substances in plants |
| 06/26/2002 | CN1355252A Hetergeneous product of bio-active protein and its preparing process |
| 06/26/2002 | CN1355046A Chinese patent medicine for treaing external malignant tumor and pyogenic infections |
| 06/26/2002 | CN1355033A Cancer-elimianting pill |
| 06/26/2002 | CN1355031A Medicine for treating tumor and its preparing process |
| 06/26/2002 | CN1355030A 'Tongyuhuazhi' pill |
| 06/26/2002 | CN1086694C 17-side chain ankynyl-and 20-oxopregna-derivatives of vitamin D, prodn. and pharmaceutical composition thereof |
| 06/26/2002 | CN1086577C Anti-tumor noval use of cinnamamide |
| 06/25/2002 | US6410802 Etherification in presence of base |
| 06/25/2002 | US6410731 Enhanced lipophilicity, bioavailability; made via a cascade radical 4+1 annulation including reacting a precursor with an arylisonitrile |
| 06/25/2002 | US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases |
| 06/25/2002 | US6410690 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 06/25/2002 | US6410590 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 06/25/2002 | US6410589 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/25/2002 | US6410575 Administering (5-aryl-1,2,4-thiadiazol)-3-yl thiourea and urea derivatives to treat hepatitis, hiv and kaposi sarcoma, as viricides and anticarcinogenic agents |
| 06/25/2002 | US6410568 Porphyrins and their use as photosensitizer |
| 06/25/2002 | US6410564 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 06/25/2002 | US6410541 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives administered as antitumor agents |
| 06/25/2002 | US6410539 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 06/25/2002 | US6410534 Anticancer agents |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents |
| 06/25/2002 | US6410509 Antigen; induce immunology response |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410328 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 06/25/2002 | US6410322 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 06/25/2002 | US6410319 CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies |
| 06/25/2002 | US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 06/25/2002 | US6410061 Tea catechins as cancer specific proliferation inhibitors |
| 06/25/2002 | US6410059 Pharmaceutical composition containing cow urine distillate and an antibiotic |
| 06/25/2002 | US6410029 2-methoxyestradiol-induced apoptosis in cancer cells |
| 06/25/2002 | US6410010 Recombinant P53 adenovirus compositions |
| 06/25/2002 | CA2245462C Methods of modulating cell proliferation through telomerase modulation |
| 06/25/2002 | CA2220024C Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 06/25/2002 | CA2217952C A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 06/25/2002 | CA2215210C Polyphenol fractions of tea, the use thereof and formulations containing them |
| 06/25/2002 | CA2208351C Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/25/2002 | CA2194393C Mammalian telomerase |
| 06/25/2002 | CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/23/2002 | WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01 |
| 06/23/2002 | CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01 |
| 06/21/2002 | CA2363799A1 Novel methods for using alkanoyloxymethyl esters |
| 06/21/2002 | CA2363758A1 Novel delta dicarbonyl compounds and methods for using same |
| 06/21/2002 | CA2363755A1 Novel acetyloxymethyl esters and methods for using same |
| 06/20/2002 | WO2002048400A1 Method of estimating risk of the expression of side effect caused by the administration of compound metabolized, either per se or as its metabolic intermediate, by ugt1a1 enzyme |
| 06/20/2002 | WO2002048390A2 Methods and kits for detecting protein kinases |
| 06/20/2002 | WO2002048370A2 Compositions and methods relating to colon specific genes and proteins |
| 06/20/2002 | WO2002048368A2 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | WO2002048366A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048365A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048349A1 Polypeptide capable of binding to heparin |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048191A2 Inhibitory agents derived from specific growth factors |
| 06/20/2002 | WO2002048182A2 Interferon-alpha induced gene |
| 06/20/2002 | WO2002048167A1 Method for generating immortal dendritic cell lines |
| 06/20/2002 | WO2002048166A1 Indolocarbazole anticancer agents and methods of using them |
| 06/20/2002 | WO2002048165A2 Antiviral agents for treatment of flaviviridae infections |
| 06/20/2002 | WO2002048153A1 Process for preparing substance gm-95 |
| 06/20/2002 | WO2002048148A2 Pyrazolopyridine derivatives |
| 06/20/2002 | WO2002048144A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 06/20/2002 | WO2002048142A1 Medicinal compositions having improved absorbability |
| 06/20/2002 | WO2002048141A1 Medicinal compositions improved in solublity in water |
| 06/20/2002 | WO2002048117A1 Quinazolinone derivatives |
| 06/20/2002 | WO2002048114A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents |
| 06/20/2002 | WO2002048112A2 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 06/20/2002 | WO2002048107A1 Antitumoral carbazoles |
| 06/20/2002 | WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/20/2002 | WO2002048092A2 Compounds for altering mitochondrial function and cellular responses |
| 06/20/2002 | WO2002047728A2 Treatment of posterior capsule opacification |
| 06/20/2002 | WO2002047727A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
| 06/20/2002 | WO2002047720A2 Treatment and prevention of ebv infection and ebv-associated disorders |
| 06/20/2002 | WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases |
| 06/20/2002 | WO2002047710A2 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer |